パイロジェン検査のグローバル市場:製品別、種類別、エンドユーザー別

P&S Market Researchが出版した調査資料(PS24MAR004)・商品コード:PS24MAR004
・発行会社(調査会社):P&S Market Research
・発行日:2023年12月
・ページ数:310
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,900 ⇒換算¥744,800見積依頼/購入/質問フォーム
Group UserUSD6,400 ⇒換算¥972,800見積依頼/購入/質問フォーム
Enterprise UserUSD8,400 ⇒換算¥1,276,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

2023年の世界のパイロジェン検査市場の売上高は1,406.4百万米ドルで、2024年から2030年にかけて年平均成長率7.3%で成長し、2,284.2百万米ドルに達すると予測されます。この市場の成長は、バイオ医薬品セクターでパイロジェン検査が受け入れられつつあることに起因しています。

さらに、バイオテクノロジーと製薬産業における発展の高まりは、新しい生物製剤の研究と導入の増加とともに、安全でより良い医薬品を製造するためのこれらの検査に対する需要を煽ると予測されます。

パイロジェン検査は、各薬剤や治療薬をより安全で効果的なものにするための重要なステップです。癌の症例数の急増と遺伝性疾患は、これらの疾患の治療において改良された治療法が利益を達成しました。

オーダーメイド医療は、人々の遺伝的プロフィールを利用して、病気の予防、診断、治療の意思決定を助けるという利点があります。そのため、患者や企業は改良された医薬品をすぐに受け入れています。さらに、臨床的特徴やゲノム的特徴に基づいた修正治療法は、がんや免疫疾患の患者の間で普及してきています。従って、改変された薬剤に対するニーズの増加は、パイロジェン検査ソリューションの需要を促進している主な理由の一つです。

エンドユーザー別では、製薬会社およびバイオテクノロジー会社のカテゴリーが2023年に35%という最大の収益シェアを占め、今後もこの傾向が続くと予想されています。この背景には、医薬品、生物製剤、新薬の製造の増加と、パイロジェン検査に対する需要の増加があります。さらに、このカテゴリーの市場成長は、個別化医療への嗜好の高まり、感染症や慢性疾患の罹患率の増加によってもたらされています。

2023年に最も売上を伸ばしたのは北米で、市場占有率は55%と最も高いです。これは、バイオテクノロジーと製薬の継続的な成長によるもので、クッキーはお客様の体験をより良いものにするために使用されます。現地市場の拡大に貢献したその他の主な要因としては、処方薬のパイプラインの拡大、医薬品承認の増加、製品の安全性と食の安全に対する意識の高まりが挙げられます。

北米地域では、米国が業界を支配しています。その主な理由は、高度な医療インフラの存在、新薬開発への集中、ファイザーやF.ホフマン・ラ・ロシュのような主要バイオテクノロジー・バイオ医薬品企業の存在です。

さらに、カナダは北米産業にも大きな利益をもたらしています。この背景には、製薬・バイオテクノロジーセクターの台頭、医薬品の安全性に関する意識の高まり、同国における研究開発活動の活発化があります。

パイロジェン検査のトッププロバイダー
Charles River Laboratories International Inc.
Merck KGaA
Thermo Fisher Scientific Inc.
FUJIFILM Wako Pure Chemical Corporation
WuXi AppTec Co. Ltd.
Microcoat Biotechnologie GmbH
Nelson Laboratories LLC
Lonza Group Ltd.
Ellab A/S
GenScript Biotech Corporation

第1章.調査範囲
第2章.調査方法
第3章.エグゼクティブサマリー
第4章.市場指標
第5章.産業動向
第6章.世界市場
第7章.北米市場
第8章.ヨーロッパ市場
第9章.アジア太平洋市場
第10章.中南米市場
第11章.中東/アフリカ市場
第12章.アメリカ市場
第13章.カナダ市場
第14章.ドイツ市場
第15章.フランス市場
第16章.イギリス市場
第17章.イタリア市場
第18章.スペイン市場
第19章.日本市場
第20章.中国市場
第21章.インド市場
第22章.オーストラリア市場
第23章.韓国市場
第24章.ブラジル市場
第25章.メキシコ市場
第26章.サウジアラビア市場
第27章.南アフリカ市場
第28章.中東市場
第29章.競争状況
第30章.企業情報
第31章.付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by type

1.4.2. Market size breakdown, by application

1.4.3. Market size breakdown, by animal

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Revenue, by Type (2017–2030)

6.3. Market Revenue, by Application (2017–2030)

6.3.1. Surgery market revenue, by type (2017–2030)

6.4. Market Revenue, by Animal (2017–2030)

6.5. Market Revenue, by End User (2017–2030)

6.6. Market Revenue, by Region (2017–2030)

Chapter 7. North America Market

7.1. Overview

7.2. Market Revenue, by Type (2017–2030)

7.3. Market Revenue, by Application (2017–2030)

7.3.1. Surgery market revenue, by type (2017–2030)

7.4. Market Revenue, by Animal (2017–2030)

7.5. Market Revenue, by End User (2017–2030)

7.6. Market Revenue, by Country (2017–2030)

Chapter 8. Europe Market

8.1. Overview

8.2. Market Revenue, by Type (2017–2030)

8.3. Market Revenue, by Application (2017–2030)

8.3.1. Surgery market revenue, by type (2017–2030)

8.4. Market Revenue, by Animal (2017–2030)

8.5. Market Revenue, by End User (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. APAC Market

9.1. Overview

9.2. Market Revenue, by Type (2017–2030)

9.3. Market Revenue, by Application (2017–2030)

9.3.1. Surgery market revenue, by type (2017–2030)

9.4. Market Revenue, by Animal (2017–2030)

9.5. Market Revenue, by End User (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. LATAM Market

10.1. Overview

10.2. Market Revenue, by Type (2017–2030)

10.3. Market Revenue, by Application (2017–2030)

10.3.1. Surgery market revenue, by type (2017–2030)

10.4. Market Revenue, by Animal (2017–2030)

10.5. Market Revenue, by End User (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. MEA Market

11.1. Overview

11.2. Market Revenue, by Type (2017–2030)

11.3. Market Revenue, by Application (2017–2030)

11.3.1. Surgery market revenue, by type (2017–2030)

11.4. Market Revenue, by Animal (2017–2030)

11.5. Market Revenue, by End User (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. U.S. Market

12.1. Overview

12.2. Market Revenue, by Type (2017–2030)

12.3. Market Revenue, by Application (2017–2030)

12.3.1. Surgery market revenue, by type (2017–2030)

12.4. Market Revenue, by Animal (2017–2030)

12.5. Market Revenue, by End User (2017–2030)

Chapter 13. Canada Market

13.1. Overview

13.2. Market Revenue, by Type (2017–2030)

13.3. Market Revenue, by Application (2017–2030)

13.3.1. Surgery market revenue, by type (2017–2030)

13.4. Market Revenue, by Animal (2017–2030)

13.5. Market Revenue, by End User (2017–2030)

Chapter 14. Germany Market

14.1. Overview

14.2. Market Revenue, by Type (2017–2030)

14.3. Market Revenue, by Application (2017–2030)

14.3.1. Surgery market revenue, by type (2017–2030)

14.4. Market Revenue, by Animal (2017–2030)

14.5. Market Revenue, by End User (2017–2030)

Chapter 15. France Market

15.1. Overview

15.2. Market Revenue, by Type (2017–2030)

15.3. Market Revenue, by Application (2017–2030)

15.3.1. Surgery market revenue, by type (2017–2030)

15.4. Market Revenue, by Animal (2017–2030)

15.5. Market Revenue, by End User (2017–2030)

Chapter 16. U.K. Market

16.1. Overview

16.2. Market Revenue, by Type (2017–2030)

16.3. Market Revenue, by Application (2017–2030)

16.3.1. Surgery market revenue, by type (2017–2030)

16.4. Market Revenue, by Animal (2017–2030)

16.5. Market Revenue, by End User (2017–2030)

Chapter 17. Italy Market

17.1. Overview

17.2. Market Revenue, by Type (2017–2030)

17.3. Market Revenue, by Application (2017–2030)

17.3.1. Surgery market revenue, by type (2017–2030)

17.4. Market Revenue, by Animal (2017–2030)

17.5. Market Revenue, by End User (2017–2030)

Chapter 18. Spain Market

18.1. Overview

18.2. Market Revenue, by Type (2017–2030)

18.3. Market Revenue, by Application (2017–2030)

18.3.1. Surgery market revenue, by type (2017–2030)

18.4. Market Revenue, by Animal (2017–2030)

18.5. Market Revenue, by End User (2017–2030)

Chapter 19. Japan Market

19.1. Overview

19.2. Market Revenue, by Type (2017–2030)

19.3. Market Revenue, by Application (2017–2030)

19.3.1. Surgery market revenue, by type (2017–2030)

19.4. Market Revenue, by Animal (2017–2030)

19.5. Market Revenue, by End User (2017–2030)

Chapter 20. China Market

20.1. Overview

20.2. Market Revenue, by Type (2017–2030)

20.3. Market Revenue, by Application (2017–2030)

20.3.1. Surgery market revenue, by type (2017–2030)

20.4. Market Revenue, by Animal (2017–2030)

20.5. Market Revenue, by End User (2017–2030)

Chapter 21. India Market

21.1. Overview

21.2. Market Revenue, by Type (2017–2030)

21.3. Market Revenue, by Application (2017–2030)

21.3.1. Surgery market revenue, by type (2017–2030)

21.4. Market Revenue, by Animal (2017–2030)

21.5. Market Revenue, by End User (2017–2030)

Chapter 22. Australia Market

22.1. Overview

22.2. Market Revenue, by Type (2017–2030)

22.3. Market Revenue, by Application (2017–2030)

22.3.1. Surgery market revenue, by type (2017–2030)

22.4. Market Revenue, by Animal (2017–2030)

22.5. Market Revenue, by End User (2017–2030)

Chapter 23. South Korea Market

23.1. Overview

23.2. Market Revenue, by Type (2017–2030)

23.3. Market Revenue, by Application (2017–2030)

23.3.1. Surgery market revenue, by type (2017–2030)

23.4. Market Revenue, by Animal (2017–2030)

23.5. Market Revenue, by End User (2017–2030)

Chapter 24. Brazil Market

24.1. Overview

24.2. Market Revenue, by Type (2017–2030)

24.3. Market Revenue, by Application (2017–2030)

24.3.1. Surgery market revenue, by type (2017–2030)

24.4. Market Revenue, by Animal (2017–2030)

24.5. Market Revenue, by End User (2017–2030)

Chapter 25. Mexico Market

25.1. Overview

25.2. Market Revenue, by Type (2017–2030)

25.3. Market Revenue, by Application (2017–2030)

25.3.1. Surgery market revenue, by type (2017–2030)

25.4. Market Revenue, by Animal (2017–2030)

25.5. Market Revenue, by End User (2017–2030)

Chapter 26. Saudi Arabia Market

26.1. Overview

26.2. Market Revenue, by Type (2017–2030)

26.3. Market Revenue, by Application (2017–2030)

26.3.1. Surgery market revenue, by type (2017–2030)

26.4. Market Revenue, by Animal (2017–2030)

26.5. Market Revenue, by End User (2017–2030)

Chapter 27. South Africa Market

27.1. Overview

27.2. Market Revenue, by Type (2017–2030)

27.3. Market Revenue, by Application (2017–2030)

27.3.1. Surgery market revenue, by type (2017–2030)

27.4. Market Revenue, by Animal (2017–2030)

27.5. Market Revenue, by End User (2017–2030)

Chapter 28. U.A.E. Market

28.1. Overview

28.2. Market Revenue, by Type (2017–2030)

28.3. Market Revenue, by Application (2017–2030)

28.3.1. Surgery market revenue, by type (2017–2030)

28.4. Market Revenue, by Animal (2017–2030)

28.5. Market Revenue, by End User (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Charles River Laboratories International Inc.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. Merck KGaA

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. Thermo Fisher Scientific Inc.

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. FUJIFILM Wako Pure Chemical Corporation

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. WuXi AppTec Co. Ltd.

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. Microcoat Biotechnologie GmbH

30.6.1. Business overview

30.6.2. Product and service offerings

30.6.3. Key financial summary

30.7. Nelson Laboratories LLC

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. Lonza Group Ltd.

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. Ellab A/S

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

30.10. GenScript Biotech Corporation

30.10.1. Business overview

30.10.2. Product and service offerings

30.10.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports



★調査レポート[パイロジェン検査のグローバル市場:製品別、種類別、エンドユーザー別] (コード:PS24MAR004)販売に関する免責事項を必ずご確認ください。
★調査レポート[パイロジェン検査のグローバル市場:製品別、種類別、エンドユーザー別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆